BSP has spent its first weeks as a covered stock pulling the lending market toward maximum stress, even as a freshly minted analyst community disagrees on what the shares are worth.
The most striking data point this week is the near-total collapse of borrow availability. Every share in the lending pool is now effectively lent out — availability has fallen to just 0.01%, down from roughly 0.25% a week ago and from a comparatively loose 130% at mid-July. That is as tight as the borrow market gets. The journey has been rapid: availability was above 100% on July 14, drifted to around 30% by late July, and has now essentially reached zero. Cost to borrow has eased off its early-July peak of nearly 30% to around 5.5%, but that decline reflects a broader re-pricing as the float got absorbed — not a sign of easing short demand. Short shares outstanding have climbed 20% in a single week to roughly 13.8 million. The borrow market is not signalling a small, manageable short position gradually being put on; it is signalling that the available lending pool has been almost entirely consumed.
Options positioning adds a further layer of caution. The put/call ratio is running at 15.8, close to its recent range, and within sight of the 52-week high of 23.7. That reading is extreme in absolute terms — far more puts than calls outstanding — and has been elevated consistently since the stock began trading. The pattern suggests options participants are treating downside protection as a baseline requirement rather than a tactical hedge.
Where the Street diverges sharply is on valuation. Seven houses initiated coverage on July 27 in a coordinated debut. The bulls — Goldman Sachs (Buy, $43), Wells Fargo (Overweight, $45), Mizuho (Outperform, $45), and Benchmark (Buy, $45) — cluster around targets 15–20% above the current price of $37.45. The sceptics — JPMorgan (Neutral, $35) and B of A Securities (Neutral, $37) — see limited near-term upside, with JPMorgan's target already below Monday's close. Bernstein sits in the middle at Outperform with a $40 target. The mean consensus sits at roughly $40.36, implying only modest upside — and that average is held up by the higher bull targets. The presence of JPMorgan and BofA at Neutral from day one is an unusual opening posture for an IPO cohort.
Ownership gives important context to the short story. The top four holders are all individuals — Luca Ferrari, Matteo Danieli, Luca Querella, and Francesco Patarnello — collectively controlling roughly 49% of shares. Cox Investment Holdings adds another 4.3%. With more than half the float locked in concentrated founder and strategic hands, the effective tradeable float for short sellers to borrow against is structurally small. That helps explain why availability tightened so aggressively even as short interest, in absolute share terms, is not yet extreme.
The ORTEX short score has crept from 60 to 64 over the past two weeks — a moderate but steadily rising bearish signal — and BSP's next earnings event is pencilled in for September 4. With the borrow pool nearly exhausted, availability already at its annual floor, and the Street split between Neutral and Buy from day one, the September print becomes the first real test of whether the bull case on acquisition-driven growth can withstand the scepticism already baked into the positioning.
See the live data behind this article on ORTEX.
Open BSP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
